Although GDF15 holds great potential in the treatment of obesity and metabolic diseases, its side effects, particularly nausea, vomiting and gastrointestinal discomfort, remain major challenges in its clinical application. The gene discussed is GDF15; the disease is obesity due to melanocortin 4 receptor deficiency.